Alpha Tau Medical Ltd logo

DRTS Earnings Date: Nov 19, 2026 (Estimated) — Alpha Tau Medical Ltd

NASDAQ · Healthcare · Biotechnology

Updated

Price $12.90
Market Cap $1.2B
P/E -12.4
52W Range $3.43 – $15.79
Next Earnings · After close (est.)

When is DRTS's next earnings date?

Alpha Tau Medical Ltd (DRTS) is expected to report Q3 2026 earnings on Thursday, November 19, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.14 on revenue of $243,250.

How did DRTS do in its last earnings report?

In its most recent report on Aug 10, 2026 (Q2 2026), Alpha Tau Medical Ltd posted EPS of -$0.50 versus the -$0.14 estimate, a miss of 257.1%. Revenue was $0 against a $144,500 estimate. The stock's 1-day post-earnings move was +4.9%.

How much does DRTS stock move after earnings?

DRTS beat EPS estimates in 2 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 5.1% (up or down) in the day after earnings.

About Alpha Tau Medical Ltd

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company is headquartered in Jerusalem, Israel.

Earnings History

DatePeriodEPS Est.EPS Act.SurpriseRevenueResult1D Δ1W Δ1M Δ
2026-08-10Q2 2026-0.14-0.50-257.14%$0❌ Miss+4.93%+4.04%+4.93%
2026-05-18Q1 2026-0.12-0.26-116.67%$0❌ Miss+6.48%+3.39%-4.19%
2026-03-09Q4 2025-0.13-0.14-7.69%$0❌ Miss+1.94%+8.05%+7.30%
2025-11-20Q3 2025-0.12-0.14-16.67%$0❌ Miss+10.09%+14.41%+46.97%
2025-08-11Q2 2025-0.12-0.13-8.33%$0❌ Miss-8.71%-8.43%+5.34%
2025-03-12Q4 2024-0.13-0.13+0.00%$0➖ Inline-1.50%-2.26%-6.01%
2024-11-19Q3 2024-0.12-0.10+16.67%$0✅ Beat-0.22%+24.35%+35.87%
2024-08-14Q2 2024-0.12-0.11+8.33%$0✅ Beat+6.64%+3.32%+10.90%

Showing last 8 quarters.

Related Companies

Learn More

Explore More

Financial data from licensed market-data providers; risk factors from SEC EDGAR filings. AI-powered analysis. Data last updated .